Ketamin Abcur (Ketamine)

Ketamine acts primarily as an antagonist of the NMDA receptor, blocking excitatory glutamate signaling in the central nervous system. This blockade produces dissociative anesthesia and analgesia. Additional mechanisms include stimulation of opioid receptors and activation of the sympathetic nervous system, which contribute to its cardiovascular profile.

The dose of Ketamin Abcur is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and the intended use (e.g., induction, sedation, or analgesia). Only a qualified health professional should set the dosing regimen.

Safety data for ketamine in pregnancy and lactation are limited, and the product’s pregnancy category is not established. Use during pregnancy or while breastfeeding should only occur if the potential benefits justify the potential risks, and after thorough evaluation by a healthcare provider.

To request Ketamin Abcur, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with traditional inhalational or opioid‑based anesthetics, ketamine provides dissociative anesthesia while preserving airway reflexes and stimulating the sympathetic nervous system, which can maintain blood pressure. It is especially useful in trauma or emergency settings where hemodynamic stability is critical, but it may cause emergence phenomena not seen with many other agents.

Ketamin Abcur should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations to maintain its stability and sterility.

Ketamin Abcur is supplied as a sterile injectable solution and can be given intravenously or intramuscularly by a qualified healthcare professional. The route, rate of injection, and total dose are determined by the clinical scenario and the prescriber’s judgment.

Serious risks include emergence reactions such as vivid hallucinations or dysphoria, respiratory depression especially when combined with other depressants, and cardiac arrhythmias or severe hypertension. Patients should be closely monitored for these events, and emergency equipment must be readily available.

Ketamin Abcur is contraindicated in patients with known hypersensitivity to ketamine or any of its excipients, those with uncontrolled hypertension, and individuals with a history of severe psychiatric disorders prone to emergence phenomena. Caution is also advised in patients with cardiovascular disease, elevated intracranial pressure, or compromised airway reflexes.